Barclays downgrades Array Technologies on weak growth outlook, margin strain
Go back to Barclays downgrades Array Technologies on weak growth outlook, margin strain| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 5.35 +0.03 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $7.27 | |||
| Open | $5.37 | 52 Week Low | $2.39 | |||
| Day High | $5.53 | P/E | N/A | |||
| Day Low | $5.28 | EPS | $-0.61 | |||
| Volume | 4,444,170 | |||||
| NYSE Arca Tech 100 ETF (NASDAQ: NXT) | Delayed: 104.88 +1.97 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.91 | 52 Week High | $25.39 | |||
| Open | $104.78 | 52 Week Low | $13.13 | |||
| Day High | $106.43 | P/E | N/A | |||
| Day Low | $103.94 | EPS | $0.00 | |||
| Volume | 1,336,605 | |||||
